Last edition
News about "GLP-1 obesity treatment"
Novo Nordisk's Wegovy Gets EU Approval for 48-Hour Controlled-Temperature Delivery
Novo Nordisk’s Wegovy becomes the first GLP-1 weight-loss treatment approved in the EU for 48-hour controlled-temperature delivery, improving storage flexibility and patient access.
GLP-1 Obesity Treatment | 11/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members